Clinical Trial Update: Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC [Phase 1]

View source ↗

Summary

Phase I trial evaluating docetaxel with low-dose fractionated radiation for metastatic or recurrent non-small cell lung cancer; the study has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Susanne Arnold | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: TERMINATED